electroCore, Inc. (ECOR)
Automate Your Wheel Strategy on ECOR
With Tiblio's Option Bot, you can configure your own wheel strategy including ECOR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ECOR
- Rev/Share 3.1919
- Book/Share 0.5266
- PB 10.1785
- Debt/Equity 0.9585
- CurrentRatio 1.5239
- ROIC -1.4284
- MktCap 39774523.0
- FreeCF/Share -1.055
- PFCF -4.5483
- PE -3.6313
- Debt/Assets 0.2608
- DivYield 0
- ROE -1.4904
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
electroCore, Inc. (ECOR) Q1 2025 Earnings Call Transcript
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Neutral
electroCore, Inc. (NASDAQ:ECOR ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Dan Goldberger - Chief Executive Officer and Director Joshua Lev - Chief Financial Officer Conference Call Participants Tyler Bussian - Brookline Capital Operator Greetings, and welcome to the electroCore First Quarter 2025 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode.
Read More
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.53 per share a year ago.
Read More
electroCore's Truvaga™ Now Works with the Apple Health app
Published: May 01, 2025 by: GlobeNewsWire
Sentiment: Neutral
ROCKAWAY, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its flagship wellness product, Truvaga Plus, now works with the Apple® Health app.
Read More
electroCore Named One of The Americas' Fastest Growing Companies by the Financial Times
Published: April 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
ROCKAWAY, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has been recognized by the Financial Times as one of “The Americas' Fastest Growing Companies 2025.
Read More
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
ROCKAWAY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Sparrow Ascent™ by Spark Biomedical, an FDA cleared non-invasive transcutaneous auricular neuromodulation device available by prescription for the treatment of opioid withdrawal symptoms, will be distributed by electroCore, Inc. within certain Department of Veterans Affairs (VA) facilities.
Read More
electroCore (ECOR) Is a Great Choice for 'Trend' Investors, Here's Why
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
electroCore (ECOR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Read More
About electroCore, Inc. (ECOR)
- IPO Date 2018-06-22
- Website https://www.electrocore.com
- Industry Medical - Devices
- CEO Mr. Daniel S. Goldberger
- Employees 73